Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
GLOBETECH PUBLISHING

New Cell Analysis System Boasts Fully Automated Reading and Imaging Features

By BiotechDaily International staff writers
Posted on 02 May 2013
Image: The BioTek Cytation3 imaging reader - Quantitative and Qualitative Data for the Total Cell Picture (Photo courtesy of BioTek).
Image: The BioTek Cytation3 imaging reader - Quantitative and Qualitative Data for the Total Cell Picture (Photo courtesy of BioTek).
A powerful new cell analysis system enables simultaneous detection and microscopic analysis of samples in microplates or microscope slices while automatically controlling temperature, shaking, and gas flow.

The new Cytation3 Cell Imagining Multi-Mode Reader is a product of BioTek (Winooski, VT, USA), a leader in the design, manufacture, and sale of microplate instrumentation and software.

Cytation3 is a cell imaging multimode reader that combines automated digital microscopy and conventional microplate detection compatible with microplates with from 6 to 384 wells and microscope slides. An optional BioStack Microplate Stacker provides increased throughput and walkaway automation for up to 50 standard microplates. The multimode microplate detection system features Biotek's patented Hybrid Technology.

The Cytation3's unique patent pending design provides rich phenotypic cellular information with well-based quantitative data. The system incorporates both high sensitivity filter-based and flexible monochromator based optics for versatility and performance. The automated digital fluorescence microscope features bright field imaging and color switching through onboard filter cubes. Red (Texas Red), green (GFP) and blue (DAPI) cubes are standard, with a fourth position available. Automated XY stage, autofocus, autoexposure, and software features increase image capture throughput, cell counting, and other tasks. Onboard objectives in a magnification range from two to 20 times allow the researcher to view an entire microplate well or to zoom in on a single cell.

Augmenting its imaging and reading capabilities, the Cytation3 offers uniform temperature control to 45 °C, variable shaking modes, and carbon dioxide and oxygen gas regulation for live-cell assays. The integrated Gen5 Data Analysis Software is simple and intuitive to use, and enables the operator to control the reader, automate the entire process, and produce publication-ready reports from the data obtained.

Related Links:
BioTek



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Diagram illustrates the innovative process that could lead to more effective drugs against influenza infection (Photo courtesy of the Hebrew University of Jerusalem).

Researchers Show How the Influenza Virus Blocks Natural Killer Cell Recognition

A team of molecular virologists has described how the influenza virus evolved a defense mechanism to protect it from attack by the immune system's natural killer (NK) cells. The recognition of pathogen-infected... Read more

Drug Discovery

view channel
Image: Synthetic ion transporters can induce apoptosis by facilitating chloride anion transport into cells (Photo courtesy of the University of Texas, Austin).

Experimental Drug Kills Cancer Cells by Interfering with Their Ion Transport Mechanism

An experimental anticancer drug induces cells to enter a molecular pathway leading to apoptosis by skewing their ion transport systems to greatly favor the influx of chloride anions. To promote development... Read more

Therapeutics

view channel
Image: Liver cells regenerated in mice treated with a new drug (right) compared with a control group (center) after partial liver removal. Healthy liver cells are shown at left (Photo courtesy of Marshall et al, 2014, the Journal of Experimental Medicine).

New Drug Triggers Liver Regeneration After Surgery

Investigators have revealed that an innovative complement inhibitor decreases complement-mediated liver cell death, and actually stimulates postsurgery liver regrowth in mice. Liver cancer often results... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.